Old Web
English
Sign In
Acemap
>
authorDetail
>
Luis E Díaz-Orozco
Luis E Díaz-Orozco
National Autonomous University of Mexico
Medicine
Intensive care medicine
Disease
Fatty liver
Type 2 Diabetes Mellitus
4
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Metabolic-associated fatty liver disease in children and adolescents: Mexican experience.
2021
The Lancet Gastroenterology & Hepatology
Nahum Méndez-Sánchez
Luis E Díaz-Orozco
Claudia Santamaría-Arza
José A. Orozco-Morales
Patricia G Medina-Bravo
Show All
Source
Cite
Save
Citations (0)
Editorial: International Consensus Recommendations to Replace the Terminology of Non-Alcoholic Fatty Liver Disease (NAFLD) with Metabolic-Associated Fatty Liver Disease (MAFLD)
2021
Medical Science Monitor
Nahum Méndez-Sánchez
Luis E Díaz-Orozco
Show All
Source
Cite
Save
Citations (0)
A Review of the Increasing Prevalence of Metabolic-Associated Fatty Liver Disease (MAFLD) in Children and Adolescents Worldwide and in Mexico and the Implications for Public Health.
2021
Medical Science Monitor
Mariana M Ramírez-Mejía
Luis E Díaz-Orozco
Beatriz Barranco-Fragoso
Nahum Méndez-Sánchez
Show All
Source
Cite
Save
Citations (2)
Nutraceuticals & microbiota: review.
2021
Luis E Díaz-Orozco
Nahum Méndez-Sánchez
Show All
Source
Cite
Save
Citations (0)
1